GWF Capital Holdings

 

GWF's PLS services provide a wide range of business consulting & data analytics services to drug & device manufacturers. Our expertise ranges from strategic work such as design of performance management frameworks, development of the commercialisation model to tracking product launch, physician profiling and segmentation. We also pride ourselves in providing operational support to pharmaceutical sales & marketing organisations through our skilled resources and intelligent in-house tools. Our flexible engagement models, ability to support across the value chain as well as a significant cost-saving proposition enable us to be an extended research & analytics team for our clients.

 

The GWF PLS team possesses immense experience in analytical & consulting roles in areas such as competitive intelligence, benchmarking, market sizing, forecasting, sales & marketing analytics, product launch & branding strategy support and big data analytics. Our technical expertise is reflected in our engagements as we provide actionable insights & recommendations as well as develop innovative solutions, which are implemented successfully. Our service offerings include:

Business Intelligence and Analysis:

 

The GWF PLS team has significant experience in pharmaceutical research and analysis. We conduct a judicious mix of primary & secondary research, and data analysis to provide our clients with actionable insights. Our business intelligence solutions include:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market Sizing and Forecasting:

 

The GWF PLS team has comprehensive market measurement skills & forecasting capabilities to estimate the market size and create forecasting models. Our skilled domain experts create hypotheses, which are tested using primary interviews of key opinion leaders (if required). SGA provides unbiased, insightful and reliable forecasts for strategy planning and risk management through the following solutions: